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Host genetic variation impacts microbiome
composition across human body sites
Ran Blekhman1,2*, Julia K. Goodrich3,4, Katherine Huang5, Qi Sun6, Robert Bukowski6, Jordana T. Bell7,
Timothy D. Spector7, Alon Keinan8, Ruth E. Ley3,4, Dirk Gevers5,9 and Andrew G. Clark3
Abstract
Background: The composition of bacteria in and on the human body varies widely across human individuals, and
has been associated with multiple health conditions. While microbial communities are influenced by environmental
factors, some degree of genetic influence of the host on the microbiome is also expected. This study is part of an
expanding effort to comprehensively profile the interactions between human genetic variation and the composition of
this microbial ecosystem on a genome- and microbiome-wide scale.
Results: Here, we jointly analyze the composition of the human microbiome and host genetic variation. By mining the
shotgun metagenomic data from the Human Microbiome Project for host DNA reads, we gathered information on
host genetic variation for 93 individuals for whom bacterial abundance data are also available. Using this dataset, we
identify significant associations between host genetic variation and microbiome composition in 10 of the 15 body
sites tested. These associations are driven by host genetic variation in immunity-related pathways, and are especially
enriched in host genes that have been previously associated with microbiome-related complex diseases, such as
inflammatory bowel disease and obesity-related disorders. Lastly, we show that host genomic regions associated
with the microbiome have high levels of genetic differentiation among human populations, possibly indicating
host genomic adaptation to environment-specific microbiomes.
Conclusions: Our results highlight the role of host genetic variation in shaping the composition of the human
microbiome, and provide a starting point toward understanding the complex interaction between human
genetics and the microbiome in the context of human evolution and disease.
Background
Recent advances in high-throughput sequencing tech-
nologies have unveiled wide variability in the microbial
communities that coat the human body [1, 2]. There are
differences in the microbiota across body sites, which
constitute distinct ecological niches [1, 3, 4]. Within
each body site, the composition of the microbiome may
change rapidly, but community features can remain
constant for years [5, 6]. There is great variability in the
microbiome across individuals, with some differences
associated with chronic conditions, including obesity,
diabetes, and inflammatory bowel disease (IBD) [7–12].
Recent studies in germ-free animals have shown that
these shifts in the microbiome can have an effect on
host traits and could be causal in disease phenotypes
[7, 12–14]. Therefore, understanding the factors that
impact the composition of the microbiome in healthy
individuals is critical to elucidate the role of the micro-
biome in disease and for development of therapeutics
targeting the microbiome.
The composition of the human microbiome is influ-
enced by multiple environmental factors. For example,
changes in host diet affect gut microbiome communities
at the taxonomic and functional level [5, 15]. In addition,
intake of drugs and antibiotics can modulate the gut
microbiome [16, 17]. Moreover, studies have shown vari-
ation in the gut microbiome can be controlled by interac-
tions with pathogens and parasites [18, 19]. Lastly, social
contact and interaction with the environment have also
been implicated in shaping the microbial flora in the gut
and skin [20–22].
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Along with this clear evidence for the influence of
environmental factors, there is also support for a host
genetic component in structuring of human microbial
communities [23]. For example, single nucleotide poly-
morphisms (SNPs) in the MEFV gene are associated
with changes in human gut bacterial community struc-
ture [24], and IBD-risk loci are associated with changes
in gut microbiome composition [25]. Researchers have
also shown that a loss-of-function polymorphism in the
gene FUT2, which is a known risk factor for Crohn’s
disease, may modulate energy metabolism of the gut
microbiome [26]. Investigating individuals with inflam-
matory bowel disease, Knights et al. have shown that
NOD2 risk allele count is correlated with an increase in
the relative abundance of Enterobacteriaceae [27].
In addition to targeted and candidate gene approaches,
researchers have also used host genome-wide genetic
variation to find interactions with the microbiome. For
example, in a recent study using 416 twin pairs to assess
the heritability of the microbiome, Goodrich et al. identi-
fied microbial taxa for which relative abundance is more
similar in monozygotic compared to dizygotic twins [14].
In the laboratory mouse, quantitative trait locus (QTL)-
mapping approaches have found multiple loci associ-
ated with gut microbial community composition, some
of which overlap genes involved in immune response
[28, 29]. Moreover, researchers have shown that host
mitochondrial DNA haplogroups are correlated with
the structure of microbiome communities [30]. How-
ever, to date, there are no genome-wide studies that
attempt to characterize specific genes and pathways in
the human genome that shape the composition of the
microbiome, although the value of such studies has
often been suggested [31, 32].
Here, we performed a genome-wide analysis to identify
human genes and pathways correlated with microbiome
composition, using data generated by the Human Micro-
biome Project (HMP). In the last few years, the HMP has
sampled and cataloged the microbial diversity across mul-
tiple body sites in a few hundred individuals [33]. Since
genotype data are not yet available for the individuals
included in the HMP study, we extracted host genomic
information from the ‘human contamination’ reads in the
HMP shotgun metagenomic sequencing. This allowed us
to generate genome-wide genetic variation data from 93
individuals, which we then tested for association with the
microbiome profiles generated by the HMP.
Results and discussion
Mining the human microbiome project data for host reads
First, we scanned and identified the short reads in the
metagenomic sequencing data that map to the human
genome. By combining these reads across body sites
(primarily originating from nares and cheek swabs [33])
for each individual (Additional file 1: Figure S1), we
attained a mean depth of coverage of more than 10 reads
per base pair per individual (Additional file 1: Figure S2).
Combining all 93 individuals, the mean depth of cover-
age for each site is 1,061 reads (median 1,093), and 99 %
of sites are covered at >500x summed across individuals.
There is noticeable variability across individuals, although
most individuals have a mean coverage in the range of
5x-20x (Additional file 1: Figure S3). We performed
genotype calling on these individuals using stringent
quality controls and filtering, and identified a final set
of 4.2 million high-quality and informative single nu-
cleotide polymorphisms (SNPs), of which 92 % were
previously known and found in dbSNP, and were used
in subsequent analyses (Additional file 1: Figures S1 to
S10). The number of SNPs we identified is in line with
previous reports using whole-genome sequencing in
humans [34].
Correlation between host genetic variation and
microbiome composition
First, we examined the correlation between host genetic
variation and the overall diversity of the microbiome. At
this point we attempted to identify gross correlation
signatures, still without accounting for population struc-
ture, and deferring the discussion of mechanistic causes
for these correlations until later in the paper. We calcu-
lated the coordinates underlying variability in the host
genetic data using multidimensional scaling (MDS). We
then calculated alpha diversity, a measure of within-
sample microbial diversity within each body site (that is,
richness within a sample), and found it to be correlated
with the first coordinate of host genetic variation data in
the anterior nares (Fig. 1a, R2 = 0.207, P = 0.039) and
the right retroauricular crease (Additional file 1: Figure
S11, R2 = 0.218, P = 0.01). In addition, we found correla-
tions in several additional coordinates; for example, the
third principal component (PC) of host genetic variation
is correlated with alpha diversity in the supragingival
plaque, the throat, and the tongue dorsum (Additional
file 1: Figure S11). Reduced alpha diversity has been
previously linked to different health conditions (for ex-
ample, inflammatory bowel disease [7], type 2 diabetes
[11], and obesity [35]), and our results suggest a possible
role for host genetics in controlling the alpha diversity.
Next, we looked for correlations of host genetics with
the overall composition of the microbiome. We found
correlations between the first host genetic principal co-
ordinate and microbiome PCs in the stool and palatine
tonsils (Fig. 1b and Additional file 1: Figure S12). We
also found correlations at a number of other body sites,
although most were not statistically significant after mul-
tiple test correction (Additional file 1: Figures S12-S17).
Nevertheless, taken together, these correlations suggest a
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potential relationship between host genetics and micro-
biome composition.
This dataset also allows us to compare between-
individual differences in the microbiome and host genetic
variation. We correlated microbial beta diversity (that is,
between-sample diversity) at each body site with genome-
wide identity-by-state, a statistic estimating similarity in
genome sequence between pairs of individuals. We found
that identity-by-state is significantly negatively corre-
lated with beta diversity in 10 of the 15 body sites
(Additional file 1: Figure S13), including in the stool
(Fig. 1c, R2 = 0.19, P <1015), anterior nares, hard palate,
palatine tonsils, saliva, supragingival plaque, throat, and
tongue dorsum (P <0.01 in each of the 10 body sites).
These results indicate that the similarity in genome
sequence is positively correlated with microbiome simi-
larity, supporting a relationship between host genetic
variation and the microbiome at a large scale. However,
this pattern may be partly driven by population stratifi-
cation, or non-genetic environmental factors that are
correlated with genetic ancestry. For example, previous
studies have found differences in the gut microbiome
between human populations [36, 37], so geographic strati-
fication could drive a biologically non-causal correlation
between genetic ancestry and local diet, and thus with gut
microbial composition.
Host genes and pathways correlated with microbiome
composition
In an effort to control for population structure, in
addition to other non-genetic factors that may be driving
spurious correlations, we analyzed the data using a linear
mixed model. The additive effects model included as co-
variates possible confounders, such as gender, sample
collection location, sequencing center, and the first five
coordinates from the MDS analysis of the host genotypic
data. By including these covariates we are attempting to
correct for effects of individual ancestry and extrinsic
factors on the microbiome. We note that there are add-
itional potential confounding factors that we could not
Fig. 1 Host genetic variation is correlated with microbiome composition. a Correlation of the first PC of host genetic data (x-axis) and alpha
diversity of the anterior nares microbiome (y-axis). b Correlation of the first PC of host genetic data (x-axis) and first PC of the stool microbiome
data (y-axis). c Identity-by-state between individual pairs calculated from host genome data (x-axis) is correlated with stool microbiome beta
diversity (y-axis), which tabulates the magnitude of pairwise differentiation between the microbiomes of same pair of individuals. In all panels,
solid and dashed gray lines represent a linear regression and loess regression fit to the data, respectively
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account for in our model; for example, physical inter-
action between individuals, which has been shown to
affect microbiome composition in primates [20], is not
included, as these data were not collected by the HMP.
We ran this model genome-wide, correlating host gen-
etic variation in each SNP with the first five PCs of the
microbiome in each of the 15 body sites. In addition to
controlling for confounders, this genome-wide approach
also allows us to identify specific loci in the host genome
that are correlated with the microbiome, and understand
their likely functional effect in the host. We recognize at
the outset that our sample size is an order of magnitude
smaller than most genome-wide association studies
(GWAS), precluding us from being able to perform a
standard test of association between microbiome com-
position and each SNP. Therefore, instead, we used a
pathway-based analysis, whereby we aggregated SNPs
into pathways in order to learn about the biological
functions and processes that underlie interactions be-
tween host genome and the microbiome. We note that
this is a common analysis approach for genome-wide as-
sociation data, driven by the rationale that complex
traits are controlled by multiple genetic effects, which
could originate in different genes, but are likely to aggre-
gate in the same biological pathway or function. The
approach is aiming to identify these functions by looking
for enrichments of biological functional categories among
a set of associated genetic loci. Specifically, we first aggre-
gated SNPs that were correlated with at least one micro-
biome PC at an arbitrary nominal cutoff of P ≤10−6 (using
several other P value thresholds did not change the re-
sults; see Additional file 2: Tables S1 and S2). We then
identified overlapping or nearby genes, and used these
gene sets to perform a functional enrichment analysis.
Using this approach, we found the most significant
enrichment with genes involved in pathway Leptin Sig-
naling in Obesity (P = 2.29 × 10−7, Additional file 2:
Table S1). Leptin is a hormone whose structure places it
in the cytokine superfamily. It has been linked to the
microbiome in several recent studies, mainly using
leptin-deficient ob/ob mice [13, 38]. Leptin has several
important roles in immunity, including activation of
monocytes, neutrophils, and macrophages, and modula-
tion of inflammation [39]. Leptin may also impact the
microbiome indirectly in its role as a hormone, whereby
it regulates appetite and body weight, affects basal me-
tabolism, and regulates insulin secretion, among other
functions [39]. The enrichment identified here is driven
by significant correlations of host genetic variation with
microbiome PCs in the nose, oral cavity, and skin (see
Additional file 2: Table S1). Studies have shown that
the leptin is expressed and has a functional role in the
mouth [40]. Leptin and leptin receptor are expressed in
the skin [41], and may have a functional role in wound
healing and psoriasis [42, 43]. Moreover, leptin is
expressed in nasal polyps, and may affect the expres-
sion of mucin genes in polyp epithelial cells [44]. Never-
theless, the role of leptin in interactions with microbial
flora in these body sites is still not well understood.
In addition to leptin signaling, several other immunity-
related pathways are enriched among microbiome-
correlated host genes, such as Melatonin Signaling, JAK/
Stat Signaling, Chemokine Signaling, CXCR4 Signaling,
and Role of Pattern Recognition Receptors in Recogni-
tion of Bacteria and Viruses (Additional file 2: Tables S1
and S2). To further investigate the role of host genetic
variation in immunity-related genes on the microbiome,
we used the InnateDB database, and identified additional
enriched pathways, including Interleukin-12-Mediated
Signaling Pathway, GABAA Receptor Activation, Inositol
Phosphate Metabolism, IL2, CXCR4-Mediated Signaling
Events, and GnRH Signaling Pathway (Additional file 2:
Tables S3 and S4). In addition, we found enrichment of
genes in the REACTOME pathway Sulfide Oxidation to
Sulfate, suggesting a potential role for host genetic vari-
ation in genes determining sulfate abundance in control-
ling microbial composition. We also found enrichment
in the KEGG pathway Primary Bile Acid Biosynthesis.
Recent studies have shown that the microbiome can
modulate bile acid metabolism [45], and our results sup-
port a possible role for host genetic variation in bile acid
metabolic pathways in interacting with the microbiota.
Next, we examined correlations between microbiome
composition and host genetic loci that had been found
to be associated with complex disease. For that purpose,
we used the GWAS catalog [46], and looked for enrich-
ment of genes found to be associated with specific com-
plex disease. For each disease in the catalog, we plotted
the overlap between the genes associated with the dis-
ease and the genes found in our study to be associated
to microbiome composition. Plotting this overlap over a
range of P value cutoffs for each GWAS dataset, we
detected enrichments in a number of diseases (Fig. 2a).
We found enrichments in genes associated with several
complex diseases for which a role for the microbiome
has been shown, such as ulcerative colitis [47], inflam-
matory bowel disease [48], obesity-related traits [7], and
HDL cholesterol and triglycerides. In addition, we found
enrichment of genes associated with metabolite levels
and metabolic traits, for which an interaction with the
microbiome has been observed [35].
We used a similar approach to identify enrichment of
SNPs annotated as expression quantitative trait loci
(eQTLs) among the sites we found to be correlated
with microbiome composition (Fig. 2b). We found an
enrichment of eQTLs in several tissues that were iden-
tified in the GTEx project [49]. This result indicates
that the loci we identified in our analysis as correlated
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with microbiome composition are likely to have a func-
tional role in regulating gene expression. Lastly, we
sought to validate our results using an independent
cohort. We followed a similar approach to identify cor-
relations between GI tract microbiome PCs and host
genetic variation in 984 individuals from the TwinsUK
project cohort [14, 50]. We find an enrichment of SNPs
correlated with microbiome composition in both studies
(Fig. 2c; P = 0.028 using Fisher’s exact test for significant
overlap between the two sets of SNPs). When considering
genes located nearby correlated SNPs, the enrichment be-
comes more prominent; possibly indicating that different
SNPs may control similar microbiome-linked genes and
pathways.
Fig. 2 Complex disease and functional SNPs are enriched among microbiome-correlated host genetic variation. a Enrichment of genes correlated
with microbiome composition (y-axis) compared to all other genes that are significantly associated with a complex disease using a given P value
threshold (x-axis). Each colored line represents a different complex disease with an enrichment of at least three-fold. b Enrichment of SNPs correlated
with microbiome composition (y-axis) compared to all other SNPs that have been identified as eQTLs in the GTEx data using a given P value threshold
(x-axis). Each colored line represents a different tissue type analyzed by GTEx. c Enrichment of SNPs (blue) and genes (red) correlated with microbiome
composition in this study (y-axis) among SNPs and genes correlated with microbiome composition in the TwinsUK dataset using a given P value
threshold (x-axis)
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Host genetic variation correlated with bacterial taxa
In addition to identifying interactions with the overall
structure of the microbiome, we were interested in
finding correlations between host genetic variation and
specific bacterial taxa. To do so, we tested for correl-
ation between genetic variation and relative abundances
of bacteria derived from the HMP 16S rRNA gene
sequences. Abundance data from HMP OTUs were
parsed, extensively filtered, normalized, and taxonomic-
ally collapsed, to achieve a single representation for each
taxon at the genus level or above (see Additional file 1:
Figures S14-S19 and Additional file 3). After filtering
inter-correlated taxa, our final dataset included 615
microbiome abundance traits in 15 body sites. In an
effort to reduce the number of statistical tests, we in-
cluded in the analysis only host SNPs located within
protein-coding sequences.
Using this approach, we found 83 associations between
genetic variation in host coding sequence and abundance
of specific microbial taxa (genome-wide false discovery
rate Q-value <0.1). These 83 associations are described in
Additional file 2: Table S5. Among these, we find several
key host genes related to immunity, such as HLA-DRA
(P = 3.72 × 10−6) and TLR1 (P = 5.04 × 10−6), which we
found to be correlated with abundance of Selenomonas
in the throat and Lautropia in the tongue dorsum, re-
spectively. Another interesting correlation was found
between host genetic variation in SNPs in the LCT gene
and the abundance of Bifidobacterium in the GI tract
(P = 1.16 × 10−5, Fig. 3a, b). LCT encodes the lactase
enzyme, which is expressed in the GI tract and acts to
hydrolyze lactose, the sugar found in dairy products. In-
triguingly, Bifidobacterium can metabolize lactose, and
reports show that some strains prefer lactose to glucose
[51]. Since genetic variants in and around LCT are
directly linked to lactase persistence [52], it is likely
that the variants we observed dictate an individual’s
consumption of milk products, which in turn may regu-
late the abundance of Bifidobacterium in the GI tract.
Although the data do not provide sufficient resolution
to discriminate the Bifidobacterium species that drives
this association, further analytical and experimental
approaches may shed light on this result.
Using pathway enrichment approaches described
above, we found that genes linked to abundance of bac-
terial taxa are over-represented with relevant diseases
(Additional file 2: Table S6), including transendothelial
migration of lymphocytes, meningitis, and several cancer
Fig. 3 Correlation between coding genetic variation and bacterial abundance. a Manhattan plot illustrating the P values (y-axis, −log scale) for
correlation of each tested coding SNP (shown as circles) by its genomic location (x-axis) with the abundance of Bifidobacterium in the gut. SNP
colors alternate by chromosome, with red dots representing SNPs with P values that surpass genome-wide significance after FDR correction. b A
close-up of the region of correlation within LCT. Genomic positions on chromosome 2 are on the x-axis, and the P values are on the y-axis (−log
scale). Each dot represents a SNP tested using our model, and the color represents the linkage disequilibrium (r2) between each dot and the top
SNP, colored purple and indicated by its dbSNP rsID (inset legend indicates the spectrum of colors and matching r2 values). Blue lines represent
recombination rate calculated from the European samples in the 1000 Genomes Project. Gene regions are shown underneath, with LCT
highlighted. c An interaction network generated using IPA showing pathways that are enriched among genes that harbor SNPs correlated with
abundance of bacterial taxa (in orange). Lines represent known interactions between genes, and shapes represent types of proteins (see legend
at the bottom left)
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categories, including gastrointestinal adenocarcinoma,
growth of mammary tumor, head and neck tumor, and
thyroid cancer. To further visualize the interactions
between these genes, we used the Ingenuity Pathway
Analysis knowledgebase, which holds curated informa-
tion on molecular pathways and protein interactions,
and identified several networks significantly enriched
with genes correlated with bacterial taxa abundances
(Additional file 2: Table S7). Figure 3c displays the
highest-scoring network, containing genes involved
with cellular movement, hematological system develop-
ment and function, and immune cell trafficking.
Lastly, we investigated the evolutionary pressures acting
on the SNPs we found to be correlated with microbiome
composition. To do so, we used FST, a measure of allele
frequency differentiation between human populations,
calculated from the 1000 Genomes Project data (see
Materials and Methods) [34]. Comparing FST between
four human populations (African, American, Asian, and
European), we found that SNPs that were linked to micro-
bial communities in our study have higher FST values
compared to the rest of the genome (Fig. 4; FDR Q <0.05
for the highlighted comparisons using a permutation test
on the medians; see Additional file 3). Interestingly, we
found that in some body sites, the microbiome is linked to
genes with higher FST values across most population com-
parisons; for example, the oral cavity microbiome is linked
to higher FST in all pairwise comparisons among popula-
tions, except Asian vs. European. In addition, specific
population pairs seem to be enriched with higher FST
across body sites; for example, both the African vs. Asian
and the American vs. Asian comparisons show high FST
values in the genes that interact with microbial communi-
ties in three of the four body sites (oral cavity, GI tract,
and airways). Overall, 12 of the 24 comparisons yielded
significantly high FST compared to the genome-wide aver-
age, while six comparisons yielded significantly lower
values.
These results suggest that host genetic variation that is
linked to microbial variation is enriched with sites that
evolve under differential selection pressures across human
populations. This is consistent with the notion of local
adaptations to population-specific microbiomes, possibly
controlled by environmental conditions for each popula-
tion. Given that genes that we found to be linked to
microbiome composition are enriched with immunity-
related genes and pathways, this result may not be surpris-
ing; indeed, genetic variation in immune genes has long
been associated with higher rated of positive selection in
human populations [53]. However, these selective pres-
sures were hypothesized to be mainly a result of inter-
action with pathogens. Our results indicate that selection
pressures on immunity genes and pathways may also be
due to interaction with commensal microbial communi-
ties that accompany changing environments. Another
potential explanation for this pattern is that past selection
pressures against pathogens have driven changes in
immunity genes that affect the commensal microbiome as
a byproduct. Although distinguishing between these hy-
potheses is not possible using currently available data, the
end result – commensal microbial traits affected by past
selection events on host genes – is an exciting finding that
we hope would be explored further in the future.
Conclusions
We describe an analysis of host genetic variation data
mined from the metagenomic shotgun sequencing per-
formed by the Human Microbiome Project. The ability
to mine host genetic material from metagenomic shot-
gun sequence data has recently raised several privacy
concerns [54]. We note that in the current study,
informed consent for sequencing of host DNA was
given by the participants, although this is not a com-
mon procedure for metagenomics studies. We show
here that it is possible to reconstruct complete host
genomes using metagenomic sequence data, which is
potentially identifiable. However, this was possible due
to the unique study design of the HMP, whereby multiple
body sites from each individual were sequenced at a high
depth, allowing us to pool data across body sites and reach
Fig. 4 SNPs correlated with microbiome composition have high FST values between human populations. Each panel represents a comparison of
a pair of human populations indicated in the title. Shown is the FST median + 95 % CI (x-axis, calculated using bootstrapping) in SNPs where
genetic variation is correlated with microbial taxa at P <10−4, separated by the body site (y-axis). Vertical dashed line represents the genome-wide
median FST. Color highlight was used in cases where FST in microbiome-correlated sites was significantly higher than the genome-wide value
(FDR Q <0.05; using a permutation test of the median)
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a 10x mean coverage per host genome. Common metage-
nomic shotgun sequencing studies, which usually include
an order of magnitude less sequence data, are unlikely to
enable such an analysis. Moreover, the majority of studies
sequence stool samples, which include many fewer host-
derived reads. Nevertheless, we anticipate that future
shotgun metagenomics sequencing studies would consider
these potential privacy concerns.
The analysis described in this paper focused on the
taxonomic structure of the microbiome. However, it
would be interesting to incorporate the functional com-
position of the microbiome when considering associations
with host genetic variation. Indeed, several studies have
highlighted the importance of shotgun metagenomics for
uncovering the genic composition and metabolic capacity
of the microbiome [1, 48]. A similar analysis would be
critical to uncover functional interactions that could not
be detected by looking at community and taxonomic
composition. In addition, there are several environmental
factors that could influence the microbiome, such as diet,
which were not included in our analysis. We expect that
the inclusion of such potential confounders in future stud-
ies would help to further disentangle the effects of envir-
onment and host genetic variation on the microbiome.
Our analysis has shown that host genetic variation in
immunity-related pathways is correlated with micro-
biome composition. These results are consistent with
recent reports of host immunity involvement in modulat-
ing microbiome structure, for example through produc-
tion of antimicrobial compounds [55] or inflammation
[56]. Additionally, many recent studies have shown that a
mice with a knocked-out immune gene display dramatic
changes in their microbiota [57–60]. Moreover, genetic
variation in immune genes in the mouse was found to be
correlated with the composition of the microbiome [61].
In addition, our results show that the host variants and
genes that are correlated with the structure of the micro-
biome are enriched in genes associated with complex dis-
ease that have been linked to the microbiome. This result
is not surprising, considering that recent studies in the
mouse have shown that microbiome QTLs overlap com-
plex disease-linked genes [28, 29]. Taken together, these
findings motivate the need for larger association studies to
characterize host genetic variation linked to the micro-
biome in the context of various health conditions, envir-
onmental effects, and genetic backgrounds. Moreover,
functional studies, for example using cells or animal
models, would be crucial for elucidating the causal mech-
anisms whereby human genetic variation impacts the
microbiome.
Materials and methods
A full and detailed description of the Methods is available
in the Additional file 3 document.
Ethical statement
Recruitment protocols were approved by Institutional
Review Boards at each HMP clinical site, and written in-
formed consent was obtained from all study participants
for data sharing through dbGap. All study participants
have consented for the sequencing of their own genetic
material [33]. Specifically, the HMP human subjects
study was reviewed by the Institutional Review Boards
(IRBs) at each sampling site: the BCM (IRB protocols H-
22895 (IRB no. 00001021) and H-22035 (IRB no.
00002649)); Washington University School of Medicine
(IRB protocol HMP-07-001 (IRB no. 201105198)); and
St Louis University (IRB no. 15778). The study was also
reviewed by the J. Craig Venter Institute under IRB
protocol 2008–084 (IRB no. 00003721), and at the Broad
Institute of MIT and Harvard the study was determined
to be exempt from IRB review.
Host read data acquisition, filtering, and alignment
The processing of the raw data files through the geno-
typing step was performed on the compute cluster at the
Broad Institute. We downloaded 1,553 raw Illumina read
files (total of 8 TB) in SRA format, representing samples
from 98 individuals (HMP subjects), from the dbGaP
database. The files were decrypted, and converted to
FASTQ format using NCBI’s SRA toolkit (version 1.0.0-
b10) with default parameters. A total of 152 files that
failed the standard Illumina quality checks were ex-
cluded from the downstream analysis. The reads from
the remaining 1,401 files were aligned to the human
genome (build hg19) using BWA v0.5.7 [62] with default
settings for the alignment, except for the ‘bwa sampe’
step, where the option ‘-a 2000’ was used to change the
maximum insert size from default 500 to 2,000. Out of
the 79,877,504,468 post-filter reads, 35,828,514,379 were
mapped to the human genome. The 1,401 BAM files
were reorganized by merging reads from different sam-
ples from the same subject into subject BAM files using
samtools [63]. The merging failed for one individual
(due to corruption of the original sample BAM files),
and for four others the merged BAM files contained
only reads from stools samples very little human DNA
present. These five subjects were excluded, leaving 93
individuals. The average number of mapped reads per
individual was 365 million.
Genotype calling, filtering, and QC
Variants (SNPs and short indels) were called from all 93
cleaned and re-aligned BAM files using the GATK’s
UnifiedGenotyper function with standard emission con-
fidence parameter set to 3.0 (−stand_emit_conf 3.0).
This value, much lower than the GATK default, was
used in order to provide an exhaustive list of possible
variants for subsequent filtering. The coverage for each
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individual was down-sampled to 200 (that is, the option
–dcov 200 was used). Other options of UnifiedGenoty-
per were kept at their default values. The calculation
was parallelized over genomic coordinates by splitting
the genome into 80,000 bp intervals and running Uni-
fiedGenotyper for each of these intervals on a separate
processor of the compute cluster. After excluding con-
tigs that did not map to a known chromosome, this
unfiltered, low-pass genotype set included 19,377,382
SNPs and 3,519,487 short InDels. In order to filter the
genotype calls and keep only high-quality variants, we
used GATK and applied several hard filters that are rec-
ommended for low-coverage whole-genome data [64].
Specifically, we excluded SNPs with low mapping qual-
ity, SNPs with a strand bias, and SNPs that are otherwise
of low quality. In addition, we masked out SNPs that are
near InDels using a window size of 10. Lastly, we excluded
any SNPs for which there is missing information and a
clear filter decision could not be made.
Next, we performed variant score recalibration on the
SNPs that have passed the above filters using the GATK
VariantRecalibrator. As input to train the model, we
used three input SNP sets: (1) HapMap3.3 SNPs; (2)
dbSNP build 132 SNPs; and (3) 1000 Genomes Project
SNPs from Omni 2.5 chip. After applying the recalibra-
tion using the GATK ApplyRecalibration command and
excluding variants that did not pass the various filters,
we were left with 13,190,940 SNPs across the 93 individ-
uals. Of this set, 7,229,492 SNPs (60.3 %) were also
found in dbSNP. As quality control, we plotted the num-
ber of sites filtered out by each filter or combination of
filters, as well as the Ti/Tv ratio for each filter combin-
ation (Additional file 1: Figure S5). The sites that passed
our filtering criteria have the highest Ti/Tv ratio (mean
2.1), which is close to the expected value observed in
many sequencing projects, including the 1000 Genomes
Project pilot data (genomic average Ti/Tv of 1.96) [65].
When we consider the frequency spectrum of alleles in
our sample (Additional file 1: Figure S6), we see an
enrichment of low-frequency variants, as consistent with
many recent population-scale sequencing studies [66].
We see a similar distribution when we consider allele
sharing across individuals (Additional file 1: Figures S8
and S9), with most alleles appearing in only one individ-
ual. Since alleles at lower frequencies are less informative
for association analysis, we excluded from downstream
analysis SNPs that are at frequency of less than 5 % in our
sample, leaving us a set of 5,536,004 SNPs. Of this set,
5,108,016 SNPs are also found in dbSNP (92.3 %). We
further filtered this set keeping only SNPs with minor al-
lele frequency above 10 %, SNP with P value >10−3 for
Hardy-Weinberg equilibrium, autosomal SNPs, and SNPs
with less than 50 % missing information. The final set
included 4,205,323 SNPs that set that passed these QC
thresholds and were used in the analysis. Pairwise
identity-by-state (IBS) distances between individuals
were calculated from the filtered SNP data using PLINK
[67, 68]. We performed metric multidimensional scaling
analysis (MDS) on the pairwise IBS distance matrix using
PLINK.
Correlation and enrichment analysis
We used the first five principal coordinates (PCs) of the
microbiome 16S data in each of the 15 body sites as
quantitative traits, which we correlated against genetic
variation in the host. Prior to running this analysis we
normalized the PC values using the Box-Cox transform-
ation with the formula
y λð Þ ¼ yλ–1 =λ
Where λ was calculated using the function box.cox.-
powers in R (in the package ‘car’). Correlation analysis of
normalized trait values was performed in PLINK v1.07
[67], and included the following covariates: (1) Individual
sex (binary variable); (2) Individual age; (3) Site where
microbiome data were collected; (4) Center where se-
quencing was performed (this was coded as binary vari-
ables representing the four collection centers: BCM
(Baylor College of Medicine), BI (Broad Institute), JCVI
(J. Craig Venter Institute), and WUGC (Washington
University Genome Center); (5) The total number of
sequences for each individual in the metagenomic se-
quencing data; and (6) The positions on the first five
dimensions in the MDS analysis of the genotype data. In
addition to the microbiome PCs, we also ran a similar
correlation analysis for a set of microbiome taxa, follow-
ing a comprehensive filtering of the 16S OTU data as
described in Additional file 3. To reduce the multiple
test burden, this analysis was performed on a set of
protein-coding host SNPs, which were identified after
annotation of the SNP data using ANNOVAR [69], and
included 33,814 protein-coding SNPs.
We considered SNPs correlated with microbiome PCs
with P value ≤10−6, and identified genes that overlap or
are located ≤50 kb from these SNPs, using data for all
known human genes taken from the refGene table (hg19
genome build). The identified genes were used as input
to functional enrichment analysis, performed using In-
genuity Pathway Analysis (IPA; August 2012 software
release), a program that uses Ingenuity’s high-quality
knowledge base, which includes curated information on
genes, pathways, and interactions (see [70]). IPA generates
a P value using a Fisher’s exact test comparing the ex-
pected and observed genes in a given pathway. The most
enriched canonical pathways are listed in Additional file 2:
Table S1. To identify the bacterial taxa driving these
enrichments, we calculated correlations between each
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OTU and the PCs in each body site. The most highly
correlated OTU for each PC where correlation with host
genetics was found is listed in Additional file 2: Table S1.
We also used the InnateDB database [71] to identify en-
richment of specific gene ontology (GO; [72, 73]) categor-
ies (Additional file 2: Table S3) and additional pathway
databases (Additional file 2: Table S4), including KEGG
[74] [75] and Reactome [76]. To make sure the specific
cutoff values chosen in this analysis do not affect the
enrichment result, we repeated this analysis with vary-
ing P value and gene distance cutoffs (see Additional
file 2: Table S2). Specifically, we used two P value cut-
offs (P ≤10−6 and P ≤5×10−7) and three gene distance
cutoffs (D ≤50 k, D ≤20 k, and D ≤5 k), and examined
the enrichment P value and rank of pathways of inter-
est (Additional file 2: Table S2).
The data from the GWAS Catalog [46] and the GTEx
consortium [49] presented in Fig. 2 were downloaded
from [77] in June 2013, and the GTEx portal [78] on
October 2013, respectively. The enrichment plots shown
in Fig. 2 were calculated as follows: given a dataset (for
example, GWAS catalog genes involved in obesity-
related traits), and given a P value cutoff (Pi, shown on
the x-axis of the figure), we identified the set of genes or
SNPs for which P ≤Pi. Next, we calculated the overlap
between Gi and the genes or SNPs identified to be corre-
lated with the microbiome in the current paper. The fold
enrichment (y-axis) for Pi is the number observed com-
pared to expected overlapping genes or SNPs, where the
expected number is the overlap among genes or SNPs
not in Gi.
To identify enrichment in an independent cohort, we
used data from the TwinsUK Project, which included
both stool microbiome 16S data, as well as host genetic
data assessed by SNP genotyping, from 984 adults [14].
OTU tables and PCs were generated using the QIIME
pipeline as described above [79–82]. Host SNP genotyp-
ing data were fully imputed using IMPUTE version
2[83], and quality checked as previously described [50].
SNPs were removed if they had a minor allele frequency
below 5 %, a genotyping rate below 95 % or extreme de-
viation from HWE (P <0.001). Deviation from HWE was
determined using the genotypes from only a single twin
from each twin pair. Only imputed SNPs with an imput-
ation accuracy score (IMPUTE INFO field) greater than
0.9 were included in the analysis. The final number of
SNPs used for the association analysis was 1,310,141. To
test for correlation between host SNPs and fecal micro-
biome PCs, we used the score test implemented in the
software Merlin [84] to account for the relatedness of the
individuals (option –fastassoc). The recombination rates
from HapMap II release 22 were used as the genetic map
input to Merlin. Model covariates included the number of
sequences per sample, sample batch, sequencing run, the
person that extracted the DNA, the gender, the age, and
the first three PCs of the MDS. After quality filtering of
traits and genotypes, 170 MZ twin pairs, 241 DZ twin
pairs, and 162 unrelated individuals were included in the
association analysis. For the analysis shown in Fig. 2c, we
used correlation P values for SNPs and nearby genes, and
calculated fold-enrichment for several P values as de-
scribed above.
FST analysis
We used FST data downloaded from the database of recent
positive selection across human populations [85] via [86]
in March 2014. We compared FST values in SNPs that
were correlated with microbiome PCs with P <10−4 in
each of the four body sites and the rest of the SNPs in our
sample. To compare two sets of FST values we used a per-
mutation test on the medians as follows: we randomly
split the data into two groups the same size of the two
original groups, and calculated the difference in medians
between the two groups. This process was repeated 10,000
times, and the P value was defined as the proportion of
permutations in which difference in medians was greater
that the real difference between the two original groups.
Figure 4 shows all the comparisons made and highlights
in color cases where the calculated P value was smaller
than 10−3. The error bars in the figure are 95 % confidence
intervals that were calculated using bootstrapping as fol-
lows: for a given set of FST values, we subsampled with
replacement a sample of the same size, and calculated the
median of the sample. This was repeated 10,000 times,
with the median recorded in each iteration. The 95 % CI
was defined as the range between the 2.5 and 97.5 percen-
tiles of all subsample medians.
Data deposition
16S rRNA gene sequence data and OTU tables are avail-
able on the HMP DACC website [87]. Host genetic data
are deposited in dbGaP under project number phs000228.
Additional files
Additional file 1: This is a PDF document containing Supplementary
Figures S1 through S19. (PDF 12238 kb)
Additional file 2: This is a PDF document containing Supplementary
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Additional file 3: This is a PDF document containing detailed
supplementary materials and methods. (PDF 300 kb)
Abbreviations
eQTL: Expression quantitative trait locus; GWAS: Genome-wide association
study; HMP: Human microbiome project; IBD: Inflammatory bowel disease;
MDS: Multidimensional scaling; OTU: Operational taxonomic unit;
PC: Principal component; QTL: Quantitative trait locus; SNP: Single
nucleotide polymorphisms.
Blekhman et al. Genome Biology  (2015) 16:191 Page 10 of 12
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
RBl performed the analysis with contributions from JKG, KH, QS, and RBu.
AGC supervised the study, and DG, REL, and AK provided comments and
discussion. RBl wrote the manuscript, with contributions from AGC, DG, and
REL. All authors read and approved the final manuscript.
Acknowledgments
We thank the members of the Blekhman, Clark, Ley, and Keinan labs for
discussions; O. Koren, T. Connallon, A. Early, L. Ma, and C. Van Hout for
comments on the manuscript; and the Human Microbiome Project for the
publically available data analyzed in this study. The work was supported by
grant R01 DK093595 to REL and AGC. DG and KH were supported by a grant
from the NIH (NIH U54 HG004969). The TwinsUK study was funded by the
Wellcome Trust; European Community’s Seventh Framework Programme
(FP7/2007-2013). The TwinsUK study also receives support from the National
Institute for Health Research (NIHR) BioResource Clinical Research Facility and
Biomedical Research Centre based at Guy’s and St Thomas’ NHS Foundation
Trust and King’s College London. TDS is holder of an ERC Advanced Principal
Investigator award. SNP genotyping of TwinsUK individuals was performed
by The Wellcome Trust Sanger Institute and National Eye Institute via NIH/
CIDR. This work was carried out in part using computing resources at the
University of Minnesota Supercomputing Institute.
Author details
1Department of Genetics, Cell Biology, and Development, University of
Minnesota, Minneapolis, MN 55455, USA. 2Department of Ecology, Evolution,
and Behavior, University of Minnesota, St. Paul, MN 55108, USA. 3Department
of Molecular Biology and Genetics, Cornell University, Ithaca, NY 14853, USA.
4Department of Microbiology, Cornell University, Ithaca, NY 14853, USA.
5Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA. 6BRC
Bioinformatics Facility, Institute of Biotechnology, Cornell University, Ithaca,
NY 14853, USA. 7Department of Twin Research & Genetic Epidemiology,
King’s College, London, UK. 8Department of Biological Statistics and
Computational Biology, Cornell University, Ithaca, NY 14853, USA. 9Current
address: Janssen Human Microbiome Institute, Janssen Research and
Development, Cambridge, MA 02142, USA.
Received: 16 June 2015 Accepted: 24 August 2015
References
1. The Human Microbiome Project Consortium. Structure, function and
diversity of the healthy human microbiome. Nature. 2012;486:207–14.
2. Costello EK, Lauber CL, Hamady M, Fierer N, Gordon JI, Knight R. Bacterial
community variation in human body habitats across space and time.
Science. 2009;326:1694–7.
3. Faust K, Sathirapongsasuti JF, Izard J, Segata N, Gevers D, Raes J, et al.
Microbial co-occurrence relationships in the human microbiome. PLoS
Comput Biol. 2012;8:e1002606.
4. Ding T, Schloss PD. Dynamics and associations of microbial community
types across the human body. Nature. 2014;509:357–60.
5. David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE, et al.
Diet rapidly and reproducibly alters the human gut microbiome. Nature.
2014;505:559–63.
6. Faith JJ, Guruge JL, Charbonneau M, Subramanian S, Seedorf H, Goodman
AL, et al. The long-term stability of the human gut microbiota. Science.
2013;341:1237439.
7. Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE, et al.
A core gut microbiome in obese and lean twins. Nature. 2009;457:480–4.
8. Wen L, Ley RE, Volchkov PY, Stranges PB, Avanesyan L, Stonebraker AC, et al.
Innate immunity and intestinal microbiota in the development of Type 1
diabetes. Nature. 2008;455:1109–13.
9. Marchesi JR, Holmes E, Khan F, Kochhar S, Scanlan P, Shanahan F, et al.
Rapid and noninvasive metabonomic characterization of inflammatory
bowel disease. J Proteome Res. 2007;6:546–51.
10. Kinross JM, Darzi AW, Nicholson JK. Gut microbiome-host interactions in
health and disease. Genome Med. 2011;3:14.
11. Qin J, Li Y, Cai Z, Li S, Zhu J, Zhang F, et al. A metagenome-wide association
study of gut microbiota in type 2 diabetes. Nature. 2012;490:55–60.
12. Koren O, Goodrich Julia K, Cullender Tyler C, Spor A, Laitinen K, Kling
Bäckhed H, et al. Host remodeling of the gut microbiome and metabolic
changes during pregnancy. Cell. 2012;150:470–80.
13. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An
obesity-associated gut microbiome with increased capacity for energy
harvest. Nature. 2006;444:1027–31.
14. Goodrich JK, Waters JL, Poole AC, Sutter JL, Koren O, Blekhman R, et al.
Human genetics shape the gut microbiome. Cell. 2014;159:789–99.
15. Turnbaugh PJ, Ridaura VK, Faith JJ, Rey FE, Knight R, Gordon JI. The effect of
diet on the human gut microbiome: a metagenomic analysis in humanized
gnotobiotic mice. Sci Transl Med. 2009;1:6ra14.
16. Vangay P, Ward T, Gerber JS, Knights D. Antibiotics, pediatric dysbiosis, and
disease. Cell Host Microbe. 2015;17:553–64.
17. Maurice CF, Haiser HJ, Turnbaugh PJ. Xenobiotics shape the physiology and
gene expression of the active human gut microbiome. Cell. 2013;152:39–50.
18. Morton ER, Lynch J, Froment A, Lafosse S, Heyer E, Przeworski M, et al.
Variation in rural African gut microbiomes is strongly shaped by parasitism
and diet. bioRxiv 2015. DOI: 10.1101/016949
19. Hoffmann C, Hill DA, Minkah N, Kirn T, Troy A, Artis D, et al. Community-wide
response of the gut microbiota to enteropathogenic Citrobacter rodentium
infection revealed by deep sequencing. Infect Immun. 2009;77:4668–78.
20. Tung J, Barreiro LB, Burns MB, Grenier JC, Lynch J, Grieneisen LE, et al. Social
networks predict gut microbiome composition in wild baboons. Elife. 2015;4
21. Meadow JF, Bateman AC, Herkert KM, O’Connor TK, Green JL. Significant
changes in the skin microbiome mediated by the sport of roller derby. Peer
J. 2013;1:e53.
22. Lax S, Smith DP, Hampton-Marcell J, Owens SM, Handley KM, Scott NM, et al.
Longitudinal analysis of microbial interaction between humans and the indoor
environment. Science. 2014;345:1048–52.
23. Spor A, Koren O, Ley R. Unravelling the effects of the environment and host
genotype on the gut microbiome. Nat Rev Micro. 2011;9:279–90.
24. Khachatryan ZA, Ktsoyan ZA, Manukyan GP, Kelly D, Ghazaryan KA, Aminov
RI. Predominant role of host genetics in controlling the composition of gut
microbiota. PLoS One. 2008;3:e3064.
25. Li E, Hamm CM, Gulati AS, Sartor RB, Chen H, Wu X, et al. Inflammatory
bowel diseases phenotype, c. difficile and NOD2 genotype are associated
with shifts in human ileum associated microbial composition. PLoS One.
2012;7:e26284.
26. Tong M, McHardy I, Ruegger P, Goudarzi M, Kashyap PC, Haritunians T, et al.
Reprograming of gut microbiome energy metabolism by the FUT2 Crohn’s
disease risk polymorphism. Isme J. 2014;8:2193–206.
27. Knights D, Silverberg MS, Weersma RK, Gevers D, Dijkstra G, Huang H, et al.
Complex host genetics influence the microbiome in inflammatory bowel
disease. Genome Med. 2014;6:107.
28. Benson AK, Kelly SA, Legge R, Ma F, Low SJ, Kim J, et al. Individuality in gut
microbiota composition is a complex polygenic trait shaped by multiple
environmental and host genetic factors. Proc Natl Acad Sci U S A.
2010;107:18933–8.
29. McKnite AM, Perez-Munoz ME, Lu L, Williams EG, Brewer S, Andreux PA, et al.
Murine gut microbiota is defined by host genetics and modulates variation of
metabolic traits. PLoS One. 2012;7:e39191.
30. Ma J, Coarfa C, Qin X, Bonnen PE, Milosavljevic A, Versalovic J, et al. mtDNA
haplogroup and single nucleotide polymorphisms structure human
microbiome communities. BMC Genomics. 2014;15:257.
31. Khor B, Gardet A, Xavier RJ. Genetics and pathogenesis of inflammatory
bowel disease. Nature. 2011;474:307–17.
32. Virgin HW, Todd JA. Metagenomics and personalized medicine. Cell.
2011;147:44–56.
33. The Human Microbiome Project Consortium. A framework for human
microbiome research. Nature. 2012;486:215–21.
34. Abecasis GR, Auton A, Brooks LD, DePristo MA, Durbin RM, Handsaker RE, et al.
An integrated map of genetic variation from 1,092 human genomes. Nature.
2012;491:56–65.
35. Le Chatelier E, Nielsen T, Qin J, Prifti E, Hildebrand F, Falony G, et al.
Richness of human gut microbiome correlates with metabolic markers.
Nature. 2013;500:541–6.
36. De Filippo C, Cavalieri D, Di Paola M, Ramazzotti M, Poullet JB, Massart S, et al.
Impact of diet in shaping gut microbiota revealed by a comparative study in
children from Europe and rural Africa. Proc Natl Acad Sci. 2010;107:14691–6.
Blekhman et al. Genome Biology  (2015) 16:191 Page 11 of 12
37. Yatsunenko T, Rey FE, Manary MJ, Trehan I, Dominguez-Bello MG, Contreras
M, et al. Human gut microbiome viewed across age and geography. Nature.
2012;486:222–7.
38. Ravussin Y, Koren O, Spor A, LeDuc C, Gutman R, Stombaugh J, et al.
Responses of gut microbiota to diet composition and weight loss in lean
and obese mice. Obesity (Silver Spring). 2012;20:738–47.
39. La Cava A, Matarese G. The weight of leptin in immunity. Nat Rev Immunol.
2004;4:371–9.
40. Groschl M, Topf HG, Kratzsch J, Dotsch J, Rascher W, Rauh M. Salivary leptin
induces increased expression of growth factors in oral keratinocytes. J Mol
Endocrinol. 2005;34:353–66.
41. Cerman AA, Bozkurt S, Sav A, Tulunay A, Elbasi MO, Ergun T. Serum leptin
levels, skin leptin and leptin receptor expression in psoriasis. Br J Dermatol.
2008;159:820–6.
42. Tadokoro S, Ide S, Tokuyama R, Umeki H, Tatehara S, Kataoka S, et al. Leptin
promotes wound healing in the skin. PLoS One. 2015;10:e0121242.
43. Zhu KJ, Zhang C, Li M, Zhu CY, Shi G, Fan YM. Leptin levels in patients with
psoriasis: a meta-analysis. Clin Exp Dermatol. 2013;38:478–83.
44. Song SY, Woo HJ, Bae CH, Kim YW, Kim YD. Expression of leptin receptor in
nasal polyps: leptin as a mucosecretagogue. Laryngoscope. 2010;120:1046–50.
45. Swann JR, Want EJ, Geier FM, Spagou K, Wilson ID, Sidaway JE, et al.
Systemic gut microbial modulation of bile acid metabolism in host tissue
compartments. Proc Natl Acad Sci U S A. 2011;108:4523–30.
46. Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, Collins FS, et al.
Potential etiologic and functional implications of genome-wide association loci
for human diseases and traits. Proc Natl Acad Sci U S A. 2009;106:9362–7.
47. Michail S, Durbin M, Turner D, Griffiths AM, Mack DR, Hyams J, et al.
Alterations in the gut microbiome of children with severe ulcerative colitis.
Inflamm Bowel Dis. 2012;18:1799–808.
48. Morgan XC, Tickle TL, Sokol H, Gevers D, Devaney KL, Ward DV, et al.
Dysfunction of the intestinal microbiome in inflammatory bowel disease
and treatment. Genome Biol. 2012;13:R79.
49. Consortium G. The Genotype-Tissue Expression (GTEx) project. Nat Genet.
2013;45:580–5.
50. Moayyeri A, Hammond CJ, Hart DJ, Spector TD. The UK Adult Twin Registry
(TwinsUK Resource). Twin Res Hum Genet. 2013;16:144–9.
51. Parche S, Beleut M, Rezzonico E, Jacobs D, Arigoni F, Titgemeyer F, et al.
Lactose-over-glucose preference in Bifidobacterium longum NCC2705: glcP,
encoding a glucose transporter, is subject to lactose repression. J Bacteriol.
2006;188:1260–5.
52. Tishkoff SA, Reed FA, Ranciaro A, Voight BF, Babbitt CC, Silverman JS, et al.
Convergent adaptation of human lactase persistence in Africa and Europe.
Nat Genet. 2007;39:31–40.
53. Quintana-Murci L, Clark AG. Population genetic tools for dissecting innate
immunity in humans. Nat Rev Immunol. 2013;13:280–93.
54. Ames SK, Gardner SN, Marti JM, Slezak TR, Gokhale MB, Allen JE. Using
populations of human and microbial genomes for organism detection in
metagenomes. Genome Res. 2015;25:1056–67.
55. Salzman NH, Hung K, Haribhai D, Chu H, Karlsson-Sjoberg J, Amir E, et al.
Enteric defensins are essential regulators of intestinal microbial ecology. Nat
Immunol. 2010;11:76–83.
56. Lupp C, Robertson M, Wickham M, Sekirov I, Champion O, Gaynor E, et al.
Host-mediated inflammation disrupts the intestinal microbiota and
promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe.
2007;2:119–29.
57. Vijay-Kumar M, Aitken JD, Carvalho FA, Cullender TC, Mwangi S, Srinivasan S,
et al. Metabolic syndrome and altered gut microbiota in mice lacking
Toll-like receptor 5. Science. 2010;328:228–31.
58. Henao-Mejia J, Elinav E, Jin C, Hao L, Mehal WZ, Strowig T, et al.
Inflammasome-mediated dysbiosis regulates progression of NAFLD and
obesity. Nature. 2012;482:179–85.
59. Garrett WS, Lord GM, Punit S, Lugo-Villarino G, Mazmanian SK, Ito S, et al.
Communicable ulcerative colitis induced by T-bet deficiency in the innate
immune system. Cell. 2007;131:33–45.
60. Caricilli AM, Picardi PK, de Abreu LL, Ueno M, Prada PO, Ropelle ER, et al.
Gut microbiota is a key modulator of insulin resistance in TLR 2 knockout
mice. PLoS Biol. 2011;9:e1001212.
61. Leamy LJ, Kelly SA, Nietfeldt J, Legge RM, Ma F, Hua K, et al. Host genetics
and diet, but not immunoglobulin A expression, converge to shape
compositional features of the gut microbiome in an advanced intercross
population of mice. Genome Biol. 2014;15:552.
62. Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler
transform. Bioinformatics. 2009;25:1754–60.
63. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al. The
Sequence Alignment/Map format and SAMtools. Bioinformatics.
2009;25:2078–9.
64. DePristo MA, Banks E, Poplin R, Garimella KV, Maguire JR, Hartl C, et al. A
framework for variation discovery and genotyping using next-generation
DNA sequencing data. Nat Genet. 2011;43:491–8.
65. Consortium TGP. A map of human genome variation from population-scale
sequencing. Nature. 2010;467:1061–73.
66. Keinan A, Clark AG. Recent explosive human population growth has
resulted in an excess of rare genetic variants. Science. 2012;336:740–3.
67. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al.
PLINK: a tool set for whole-genome association and population-based
linkage analyses. Am J Hum Genet. 2007;81:559–75.
68. PLINK: Whole genome association analysis toolset. Available at: http://
pngu.mgh.harvard.edu/~purcell/plink.
69. Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic
variants from high-throughput sequencing data. Nucleic Acids Res.
2010;38:e164.
70. Ingenuity Pathway Analysis. Available at: www.ingenuity.com.
71. Innate DB. Available at: www.innatedb.com
72. Consortium TGO. The Gene Ontology in 2010: extensions and refinements.
Nucleic Acids Res. 2010;38:D331–5.
73. Gene Ontology Consortium. Available at: www.geneontology.org.
74. KEGG: Kyoto Encyclopedia of Genes and Genomes. Available at:
www.genome.jp/kegg.
75. Kanehisa M, Goto S, Sato Y, Furumichi M, Tanabe M. KEGG for integration
and interpretation of large-scale molecular data sets. Nucleic Acids Res.
2012;40:D109–14.
76. Reactome. Available at: www.reactome.org.
77. National Human Genome Research Institute. Available at:
www.genome.gov/26525384.
78. GTex Portal. Available at: www.broadinstitute.org/gtex/.
79. Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello
EK, et al. QIIME allows analysis of high-throughput community sequencing
data. Nat Methods. 2010;7:335–6.
80. Edgar RC. Search and clustering orders of magnitude faster than BLAST.
Bioinformatics. 2010;26:2460–1.
81. Caporaso JG, Bittinger K, Bushman FD, DeSantis TZ, Andersen GL, Knight R.
PyNAST: a flexible tool for aligning sequences to a template alignment.
Bioinformatics. 2010;26:266–7.
82. Price MN, Dehal PS, Arkin AP. FastTree 2–approximately maximum-likelihood
trees for large alignments. PLoS One. 2010;5:e9490.
83. Howie BN, Donnelly P, Marchini J. A flexible and accurate genotype
imputation method for the next generation of genome-wide association
studies. PLoS Genet. 2009;5:e1000529.
84. Abecasis GR, Cherny SS, Cookson WO, Cardon LR. Merlin–rapid analysis of
dense genetic maps using sparse gene flow trees. Nat Genet. 2002;30:97–101.
85. Li MJ, Wang LY, Xia Z, Wong MP, Sham PC, Wang J. dbPSHP: a database of
recent positive selection across human populations. Nucleic Acids Res.
2014;42:D910–6.
86. dbPSHP: A database of recent positive selection across human populations.
Available at: http://jjwanglab.org/dbpshp.
87. NIH Human Microbiome Project. Available at: http://hmpdacc.org.
Blekhman et al. Genome Biology  (2015) 16:191 Page 12 of 12
